Boston Scientific (BSX) Change in Accured Expenses (2020 - 2026)

Boston Scientific's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$512.0 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 32.99% year-over-year to -$512.0 million; the TTM figure through Mar 2026 stood at $169.0 million (down 45.13% YoY), while the FY2025 annual figure was $296.0 million, up 21.81% from the prior year.
• Change in Accured Expenses came in at -$512.0 million for Q1 2026 at Boston Scientific, down from $285.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $385.0 million in Q4 2024 to a low of -$512.0 million in Q1 2026.
• A 5-year average of -$6.5 million and a median of $23.0 million in 2023 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses sank 5357.14% in 2022 and jumped 1573.91% in 2024, its largest moves.
• Boston Scientific's Change in Accured Expenses stood at $335.0 million in 2022, then slumped by 93.13% to $23.0 million in 2023, then surged by 1573.91% to $385.0 million in 2024, then decreased by 25.97% to $285.0 million in 2025, then slumped by 279.65% to -$512.0 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$512.0 million, $285.0 million, and $165.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison